Access to Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Access to Clinical Trials in Brazil

Access to Clinical Trials in Brazil – Clinical Trials in LATAM

Clinical trials are the cornerstone of medical advancement, contributing to the development of new treatments, therapies, and medical technologies. Brazil, with its vast population, robust healthcare system, and thriving research community, has emerged as a key player in the field of clinical trials.

This blog aims to explore the landscape of clinical trials in Brazil, shedding light on the benefits, challenges, and initiatives taken to enhance access to these trials for individuals across the country.

The Importance of Clinical Trials

Clinical trials serve as a critical bridge between scientific research and patient care. They provide a platform to evaluate the safety, effectiveness, and side effects of new interventions, ensuring that patients receive the most promising and evidence-based treatments.

Engaging in clinical trials not only offers patients access to innovative therapies but also empowers them by contributing to medical progress and shaping the future of healthcare.

Brazil’s Advantages as a Clinical Trial Destination

Brazil possesses several key strengths that make it an attractive location for clinical trials. Its diverse and genetically varied population enables researchers to conduct studies that reflect global demographics, enhancing the generalizability of research findings.

The country also boasts a robust healthcare infrastructure, with renowned medical centers, research institutions, and universities that foster collaboration and provide state-of-the-art facilities for conducting trials. Additionally, Brazil has a large pool of highly skilled healthcare professionals and scientists, contributing to the success of clinical research.

Regulatory Framework and Ethical Considerations

Brazil has implemented a comprehensive regulatory framework for clinical trials to ensure patient safety and ethical conduct. The National Health Surveillance Agency (ANVISA) oversees the approval and monitoring of clinical trials, following international guidelines and ethical standards.

This regulatory structure promotes transparency, data integrity, and participant protection, instilling confidence in both participants and sponsors.

Access to Clinical Trials in Brazil

Access to Clinical Trials in Brazil

Access to Clinical Trials in Brazil

Challenges in Access to Clinical Trials

Despite the favorable environment, access to clinical trials in Brazil faces certain challenges. Limited awareness among the general public about the significance and benefits of clinical research can hinder participation rates.

Language barriers and low health literacy levels may further exacerbate disparities, particularly among marginalized populations. Financial constraints and geographical barriers can also impede access for individuals living in remote or underserved areas.

Initiatives to Enhance Access

Brazil is taking proactive steps to improve access to clinical trials and promote inclusivity. Educational campaigns and community engagement programs aim to raise awareness about the importance of clinical trials, debunk myths, and address misconceptions.

Collaborations between research institutions, government bodies, and patient advocacy groups facilitate information dissemination and promote patient-centric approaches. Furthermore, initiatives focused on reaching underserved populations, such as mobile clinics and telemedicine, are bridging gaps and expanding access to trials.

Patient Empowerment and Collaboration

Empowering patients and involving them as active partners in the clinical trial process is essential for enhancing access. Providing clear and accessible information about trials, informed consent, and patient rights fosters trust and promotes shared decision-making.

Open communication channels between patients, healthcare providers, and researchers enable dialogue, address concerns, and ensure that trials are designed to meet the diverse needs of the population.


Brazil’s commitment to expanding access to clinical trials holds great potential for medical advancements and improved patient outcomes. By leveraging its diverse population, robust healthcare infrastructure, and supportive regulatory framework, Brazil is poised to continue playing a pivotal role in advancing medical research.

Efforts to overcome challenges, promote patient empowerment, and foster collaboration will drive progress, ensuring that individuals across the country have equal opportunities to participate in and benefit from clinical trials.

In conclusion, Brazil’s access to clinical trials is steadily improving, driven by its favorable regulatory environment, strong healthcare infrastructure, and proactive initiatives. By harnessing its diverse population and promoting patient-centric approaches, Brazil is paving the way for medical breakthroughs and fostering inclusivity in clinical research.

Continued efforts to raise awareness, address barriers, and enhance collaboration between stakeholders will contribute to the growth of clinical trials in Brazil, ultimately improving healthcare outcomes and empowering patients in their journey towards better health.

Access to Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Access to Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Access to Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Access to Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Access to Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Access to Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Access to Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Access to Clinical Trials in Brazil

The Cohortias Team

Access to Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Access to Clinical Trials in Brazil

Network & Partnerships